Description

Oraclor ( cefaclor ) is a semisynthetic cephalosporin antibiotic for oral administration.

Composition

Each 5 mL of Oraclor Oral Suspension contains:

• Cefaclor base: 250 mg.
• Excipients: S.Q. for 5 mL.

Indications

Oraclor is indicated in the treatment of the following infections:

• Otitis Media: caused by streptococcus pneumoniae, haemophilus influenzae, staphylococci, and streptococcous pyogenes.
• Lower respiratory tract infections: including pneumonia caused by streptococcus pneumoniae, haemophilus influenzae and streptococcus pyogenes.
• Pharyngitis and tonsillitis: caused by streptococcus pyogenes.

Oraclor is generally effective in the eradication of streptococci from the nasopharynx.

• Urinary Tract Infections: including pyelonephritis and cystitis, caused by E.coli, proteus mirabilis, klebsilla spp. and coagulase-negative staphylococci.
• Skin and skin structure infections :caused by staphylococcus aureus and streptococcus pyogenes.

Dosage & Administration

Adults:

The usual adult dosage is 250 mg every 8 hours, for more severe infections such as pneumonia, doses may be doubled.

Pediatric Patients:

The usual recommended daily dosage for pediatric patients is 20 mg/ kg / day in divided doses every 8 hours.

In more serious infection and otitis media, 40mg/ kg/ day are recommended, with a maximum dosage of 1g/ day.

Note: For the treatment of otitis media and pharyngitis, the total daily dosage may be divided and administered every 12 hours.

Oraclor may be administered in the presence of impaired renal function the dosage usually is unchanged.

In the treatment of β -hemolytic streptococcal infections a therapeutic dosage of Oraclor should be administered for at least 10 days.